Skip to content

Clinical trials

Phase 1/2 Cognitive Dysfunction trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1/2 Status: Unknown status Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20151
20192
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adeona Pharmaceuticals1
Beni-Suef University1
Oregon Health and Science University1
Posit Science Corporation1
Seoul National University Bundang Hospital1
The First Hospital of Hebei Medical University1
Universidad Antonio de Nebrija1
University Medical Center Groningen1
University of Genova1
Yangzhou University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction10
Alzheimer Disease4
Gastrointestinal Neoplasms1
Neurodegenerative Diseases1
Parkinson Disease1
Post-Acute COVID-19 Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.